Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Frequent EpCam protein expression in human carcinomas.

Went PT, Lugli A, Meier S, Bundi M, Mirlacher M, Sauter G, Dirnhofer S.

Hum Pathol. 2004 Jan;35(1):122-8.

PMID:
14745734
2.

Epithelial cell adhesion molecule expression (CD326) in cancer: a short review.

Patriarca C, Macchi RM, Marschner AK, Mellstedt H.

Cancer Treat Rev. 2012 Feb;38(1):68-75. doi: 10.1016/j.ctrv.2011.04.002. Review.

PMID:
21576002
3.

EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis.

Spizzo G, Fong D, Wurm M, Ensinger C, Obrist P, Hofer C, Mazzoleni G, Gastl G, Went P.

J Clin Pathol. 2011 May;64(5):415-20. doi: 10.1136/jcp.2011.090274.

4.

Subtypes of cervical adenosquamous carcinomas classified by EpCAM expression related to radiosensitivity.

Imadome K, Iwakawa M, Nakawatari M, Fujita H, Kato S, Ohno T, Nakamura E, Ohkubo Y, Tamaki T, Kiyohara H, Imai T.

Cancer Biol Ther. 2010 Nov 15;10(10):1019-26. doi: 10.4161/cbt.10.10.13249.

PMID:
20855955
5.

Epithelial cell adhesion molecule (KSA) expression: pathobiology and its role as an independent predictor of survival in renal cell carcinoma.

Seligson DB, Pantuck AJ, Liu X, Huang Y, Horvath S, Bui MH, Han KR, Correa AJ, Eeva M, Tze S, Belldegrun AS, Figlin RA.

Clin Cancer Res. 2004 Apr 15;10(8):2659-69.

6.

Expression of epithelial cell adhesion molecule (EpCam) in renal epithelial tumors.

Went P, Dirnhofer S, Salvisberg T, Amin MB, Lim SD, Diener PA, Moch H.

Am J Surg Pathol. 2005 Jan;29(1):83-8.

PMID:
15613858
7.

Loss of membranous expression of the intracellular domain of EpCAM is a frequent event and predicts poor survival in patients with pancreatic cancer.

Fong D, Moser P, Kasal A, Seeber A, Gastl G, Martowicz A, Wurm M, Mian C, Obrist P, Mazzoleni G, Spizzo G.

Histopathology. 2014 Apr;64(5):683-92. doi: 10.1111/his.12307.

PMID:
24117877
8.

Epithelial cell adhesion molecule is an independent prognostic marker in clear cell renal carcinoma.

Eichelberg C, Chun FK, Bedke J, Heuer R, Adam M, Moch H, Terracciano L, Hinrichs K, Dahlem R, Fisch M, Schlomm T, Sauter G, Minner S.

Int J Cancer. 2013 Jun 15;132(12):2948-55. doi: 10.1002/ijc.27970.

9.

EpCAM Aptamer-siRNA Chimera Targets and Regress Epithelial Cancer.

Subramanian N, Kanwar JR, Kanwar RK, Sreemanthula J, Biswas J, Khetan V, Krishnakumar S.

PLoS One. 2015 Jul 15;10(7):e0132407. doi: 10.1371/journal.pone.0132407.

10.

Clinicopathological implications of EpCAM expression in adenocarcinoma of the lung.

Kim Y, Kim HS, Cui ZY, Lee HS, Ahn JS, Park CK, Park K, Ahn MJ.

Anticancer Res. 2009 May;29(5):1817-22.

11.

EpCAM: A new therapeutic target for an old cancer antigen.

Armstrong A, Eck SL.

Cancer Biol Ther. 2003 Jul-Aug;2(4):320-6. Review.

PMID:
14508099
12.

Expression of epithelial cell adhesion molecule in gallbladder carcinoma and its correlation with clinicopathologic variables.

Prince S, Zeidman A, Dekel Y, Ram E, Koren R.

Am J Clin Pathol. 2008 Mar;129(3):424-9. doi: 10.1309/H8JEEAEB69J3KYND.

13.

EpCAM expression in squamous cell carcinoma of the oral cavity: frequency and relationship to clinicopathologic features.

Laimer K, Fong D, Gastl G, Obrist P, Kloss F, Tuli T, Gassner R, Rasse M, Norer B, Spizzo G.

Oral Oncol. 2008 Jan;44(1):72-7.

PMID:
17418618
14.

EpCAM and its potential role in tumor-initiating cells.

Imrich S, Hachmeister M, Gires O.

Cell Adh Migr. 2012 Jan-Feb;6(1):30-8. doi: 10.4161/cam.18953. Review.

15.

Selective gene delivery toward gastric and esophageal adenocarcinoma cells via EpCAM-targeted adenoviral vectors.

Heideman DA, Snijders PJ, Craanen ME, Bloemena E, Meijer CJ, Meuwissen SG, van Beusechem VW, Pinedo HM, Curiel DT, Haisma HJ, Gerritsen WR.

Cancer Gene Ther. 2001 May;8(5):342-51.

16.

Identification of DNA aptamers toward epithelial cell adhesion molecule via cell-SELEX.

Kim JW, Kim EY, Kim SY, Byun SK, Lee D, Oh KJ, Kim WK, Han BS, Chi SW, Lee SC, Bae KH.

Mol Cells. 2014 Oct 31;37(10):742-6. doi: 10.14348/molcells.2014.0208.

17.

EpCAM expression in the prostate cancer makes the difference in the response to growth factors.

Yoshida GJ, Saya H.

Biochem Biophys Res Commun. 2014 Jan 3;443(1):239-45. doi: 10.1016/j.bbrc.2013.11.093.

PMID:
24309103
18.

Expression of EpCam and villin in Barrett's esophagus and in gastric cardia.

Anders M, Sarbia M, Grotzinger C, Meining A, Hofler H, Wiedenmann B, Rosch T.

Dis Markers. 2008;24(6):287-92.

19.

EpCAM overexpression in thyroid carcinomas: a histopathological study of 121 cases.

Ensinger C, Kremser R, Prommegger R, Spizzo G, Schmid KW.

J Immunother. 2006 Sep-Oct;29(5):569-73.

PMID:
16971812
Items per page

Supplemental Content

Support Center